May 27, 2020
Alkermes Highlights New Data From Schizophrenia Portfolio at the American Society of Clinical Psychopharmacology 2020 Annual Meeting
May 27, 2020
Relmada Therapeutics Announces Outcome of End-of-Phase 2 Meeting with FDA for REL-1017 for Adjunctive Treatment of Patients with Major Depressive Disorder
May 27, 2020
The Ketamine Healing Clinic of Los Angeles, California, is Offering New "Fountain of Youth Infusion" with the Combination of NAD and Ketamine
May 27, 2020
Research in Opioid Utilization, Migraine Therapy and Preterm Birth Recognized with AMCP Foundation Best Poster Awards
May 26, 2020
Bexson Biomedical Announces Two New Appointments to Board of Directors
May 26, 2020
Psychedelics Begin Gradual Climb to Medical Status
May 25, 2020
/R E P E A T -- New Wave Holdings Sponsors Non-Profit Coalition, Therapsil, to Launch a Medical Psilocybin Access Project for Canadians in Palliative Care/
May 24, 2020
New Wave Holdings Sponsors Non-Profit Coalition, Therapsil, to Launch a Medical Psilocybin Access Project for Canadians in Palliative Care
May 21, 2020
Annual Deaths Due to Alcohol, Drugs or Suicide Exceeded 150,000 According to the Most Recent Data --And Could Get Worse Due to COVID-19
May 21, 2020
Leading Cannabis Industry Website MarijuanaBreak Announces Name Change to WayofLeaf.com
May 21, 2020
Insomnia Data 2020: US Leads in Global Insomnia Clinical Trials, Germany Leads Major European Markets and Japan Has Top Spot in Asia
May 20, 2020
ABSTRAX Announces Cannabis Analysis Services and Custom Terpene Formulations for Brands Seeking to Offer Strain Specific "Designer Highs"
May 20, 2020
Opioid prescribing rates on 14-year decline in pediatric orthopaedic injuries, decreased by more than 50%
May 20, 2020
Neurelis Announces Total Of Nine Poster Presentations For The AANN, AMCP, And AAN Annual Meetings
May 20, 2020
Journal of Clinical Psychiatry Publishes Data from Alkermes' ALPINE Study in Patients With Schizophrenia
May 19, 2020
NewLeaf Brands' Wholly Owned Subsidiary Mydecine Group, LLC Announces the Build Out of a Specialty Mycology Lab in Denver, Colorado
May 18, 2020
Heron Therapeutics Announces Initiation of Phase 1b/2 Clinical Study of HTX-034 for the Treatment of Postoperative Pain
May 15, 2020
Titan Pharmaceuticals Reports First Quarter 2020 Financial Results
May 14, 2020
Alkermes Presents New Data From Schizophrenia Portfolio at Virtual 2020 Congress of the Schizophrenia International Research Society
May 14, 2020
Achieve Reports Financial Results for First Quarter 2020 and Provides Update on Cytisinicline Development Program